Kaan Certel - 31 May 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMGA	Stock Option (Right to Buy)	Award	$0	+220,000		$0.000000	220,000	31 May 2024	Common Stock	220,000	$1.98	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests and becomes exercisable with respect to 25% of the underlying shares on May 28, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on May 28, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.